Amyloid Solution Investor

Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.


Invests into

Last Funding Type: Series B
Funding Status: Late Stage Venture
Headquarters: Bundangdong, Kyonggi-do, South Korea
Founded Date: 2017-01-01
Investor Type: For Profit
Last Funding Date: 2020-04-16
Total Funding: 27439551.0
Technology: Geroscience
Employee Number: 11-50
Investors Number: 1
Industry: Biotechnology, Health Care, Therapeutics